WHO ARE WE?
THE URGO GROUP
Since its creation in 1958, the Urgo Group has been on a mission : change patient’s lives through innovative healthcare and healing solutions.
INVESTING IN R&D
Our international cutting-edge research laboratories allow us to guarantee our patients best-in-class products with clinically proven effectiveness.
200
employees dedicated to R&D
55
clinical & observational studies since 1997
300M€
R&D investments (2020-2030)
80M€
invested in plants (2020-2030)
Urgo Surgical
Urgo Surgical is a business unit within the Urgo Group. It was founded in 2017 and provides cutting edge innovations aiming to optimize acts of aesthetic surgery.
UrgoTouch is the first product in the Urgo Surgical portfolio. Its developement spans over more than 15 years, showing the Urgo’s commitment to R&D, excellence and patient wellbeing.
Urgo Surgical is currently present in the French and Spanish markets where more than 30,000 patients have benefited from our treatment thanks to over 300 surgeons who trust our medical device.

